There’s a new weight loss drug that is still in research that is making headlines — and the results are turning heads.Eli Lilly just announced Phase 3 clinical trial results for an investigational medication called retatrutid
There’s a new weight loss drug that is still in research that is making headlines — and the results are turning heads.Eli Lilly just announced Phase 3 clinical trial results for an investigational medication called retatrutid
Xylitol was linked to a higher risk of heart attack, stroke, or cardiovascular death.
Paracetamol, also called acetaminophen, taken during pregnancy was linked to smaller ovaries and fewer egg-containing follicles in daughters.
And a review study found that for esophageal cancer, adding surgery after chemoradiation was linked to better survival than chemoradiation alone.
Medications are another key part of treatment. Catechol O-methyltransferase inhibitors, or COMT inhibitors, were strongly recommended to help manage movement-related symptoms.
Persistent, severe abdominal pain—especially if it spreads to the back—could be a sign of pancreatitis. In that case, the medication should be stopped and urgent medical evaluation is needed.
https://youtube.com/shorts/0FvRWLm5OOg
GLP-1 receptor agonists are medications used for weight loss and type 2 diabetes. They help people feel full sooner, eat less, and improve blood sugar control. But while these medications are effective, many people worry about stomach side effects.